Sort
326,823 grants matching “clinical trial”
DATA RESOURCE FOR ANALYZING BLOOD AND MARROW TRANSPLANTS
$2,240,145Medical College Of Wisconsin · U24 · FY2000 · CA
TAS::75 0850::TAS RECOVERY ACT - ADOPTION OF NEW TECHNOLOGIES FOR REMOTE DATA CA
$2,240,090Stephen Riordan · Westat, Inc. · N02 · FY2009 · CA
WIHS Data Management and Analysis Center (WDMAC)
$2,240,055Stephen John Gange · Johns Hopkins University · U01 · FY2013 · AI
SPORE in Lung Cancer
$2,240,006University Of Colorado Denver · P50 · FY2003 · CA
Integrated Molecular, Cellular, and Imaging Characterization of Screen-Detected Lung Cancer
$2,239,851Steven M. Dubinett · University Of California Los Angeles · U01 · FY2016 · CA
Integrative Oncogenomics of Multiple Myeloma
$2,239,580Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2025 · CA
PREVENTABLE Trial Implementation Phase
$2,238,866Karen P Alexander · Duke University · U19 · FY2023 · AG
NORTHWESTERN ADULT AIDS CLINICAL TRIALS UNIT
$2,238,755Northwestern University · U01 · FY2003 · AI
Next generation T cell therapies for mutant KRAS solid tumors
$2,238,704Beatriz M. Carreno · University Of Pennsylvania · UH3 · FY2025 · CA
Innovative Strategies to Combat Antibiotic-resistant Infections
$2,238,702Scott J Hultgren · Washington University · U19 · FY2024 · AI
Neurologic Emergencies Treatment Trials Network: Clinical Coordinating Center
$2,238,570William G Barsan · University Of Michigan At Ann Arbor · U01 · FY2011 · NS
Medical University of South Carolina - Cancer Center Support Grant
$2,238,339Raymond Nelson Dubois · Medical University Of South Carolina · P30 · FY2025 · CA
PACT
$2,238,211Adrian Gee · Baylor College Of Medicine · N01 · FY2014 · HL
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$2,238,200David S Stephens · Emory University · UL1 · FY2008 · RR
Prescribing Cascades among Nursing Home Residents with ADRD
$2,238,104Andrew Reis Zullo · Brown University · RF1 · FY2024 · AG
IND-enabling Preclinical Studies on Anti-Tau AD Vaccine for Phase 1 Trial
$2,237,972Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2022 · AG
Evolution and Treatment Response of Brain, Breast, and Hematologic Malignancies
$2,237,877Franziska Michor · Dana-Farber Cancer Inst · U54 · FY2016 · CA
Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials Unit
$2,237,757Scott M Hammer · Columbia University Health Sciences · UM1 · FY2016 · AI
Integrative Pathophysiology of Solid Tumors
$2,237,643Rakesh K. Jain · Massachusetts General Hospital · P01 · FY2016 · CA
Using Genetics For Early Phenotyping & Prevention of Hypertrophic Cardiomyopathy
$2,237,613Carolyn Y Ho · Brigham And Women'S Hospital · P50 · FY2015 · HL
Brain Tumor Clinical and Clinical Research Program
$2,237,606Mark Gilbert · Division Of Basic Sciences - Nci · ZID · FY2023 · CA
Gene therapy of cancer
$2,237,547Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Adoptive Cell Transfer Immunotherapy of Cancer
$2,237,547Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Gene-engineered adoptive T cell immunotherapy of GBM
$2,237,545Laura A Johnson · University Of Pennsylvania · DP2 · FY2012 · CA
Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer
$2,237,511Brian Matthew Wolpin · Dana-Farber Cancer Inst · P50 · FY2020 · CA